Lantern Pharma Inc (LTRN) Q4 2025 Earnings Call Transcript

Why It Matters

The results demonstrate nLIGHT’s successful pivot to high‑margin defense laser programs, strengthening its balance sheet and positioning it to capture expanding government demand for directed‑energy systems.

Key Takeaways

• Full-year revenue hit $261M, up 32% YoY.
• A&D segment grew 60% to $175M record.
• Exiting cutting and welding adds $25‑30M revenue headwind.
• $190M equity raise boosts cash to over $250M.
• Adjusted EBITDA turned positive $23.5M for 2025.

Pulse Analysis

The directed‑energy market is entering a rapid expansion phase as U.S. defense priorities shift toward non‑kinetic missile defense and counter‑UAS capabilities. nLIGHT’s vertically integrated laser technology, spanning from chip‑level components to full weapon modules, gives it a competitive edge in securing large government contracts such as the $171 million HELSI‑2 program. By delivering a 50‑kilowatt laser for the DE M‑SHORAD initiative and scaling fiber‑amplifier production, the company has capitalized on a surge in demand from both domestic and allied customers, reinforcing its position as a core supplier in the defense supply chain.

Financially, nLIGHT transformed its profit profile in 2025, lifting gross margins from 17% to 30% and turning adjusted EBITDA positive for the first time. The $190 million equity raise not only fortified its cash position—exceeding $250 million—but also funded a new 50,000‑square‑foot manufacturing facility in Longmont, Colorado, aimed at accelerating high‑volume laser production. Simultaneously, the strategic exit from the cutting and welding segment trims low‑margin exposure, albeit introducing a short‑term revenue drag of up to $30 million. This disciplined capital allocation underscores management’s focus on scaling high‑margin A&D offerings while preserving financial flexibility.

Looking ahead, nLIGHT’s backlog remains robust at roughly $162 million, and its 2026 guidance anticipates continued revenue growth despite the anticipated dip in development income after the DE M‑SHORAD delivery. The company’s outlook is closely tied to the timing of future government awards, especially under the Golden Dome executive order that prioritizes domestic production of directed‑energy systems. If nLIGHT can sustain its execution momentum and translate pipeline opportunities into contracts, it stands to benefit from the broader defense modernization trend and solidify its market share in the burgeoning laser weapons arena.